Related Experiment Video
Updated: Aug 1, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Bufalin serves as a pharmaceutic that mitigates drug resistance
Linxuan Miao1, Ying Liu1,2, Nasra Mohamoud Ali1
1Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, P.R. China.
Abstract:
Intrinsic or acquired drug resistance of tumor cells is the main cause of tumor chemotherapy failure and tumor-related death. Bufalin (BF) is the main active monomer component extracted from the Traditional Chinese Medicine Toad venom (secretions of glands behind the ears and epidermis of bufo gargarizans and Bufo Melanostictus Schneider). It is a cardiotonic steroid with broad-spectrum anti-cancer effects and has been widely used against various malignant tumors in clinical practice. Pharmacological studies also found that BF has the effect of reversing drug resistance, which provides a new perspective for the application of Traditional Chinese Medicine as a chemosensitizer in cancer therapy. This article provides an extensive search and summary of published research on mitigating drug resistance to BF and reviews its potential mechanisms.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Desensitization and Tachyphylaxis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
CNS Depressants: Barbiturates and Benzodiazepines
Development of Antibiotic Resistance
Drug Therapy
Antianxiety Medications

